Journal of Clinical and Scientific Research (Jan 2019)

Pathophysiology of matrix metalloproteinases in breast cancer progression

  • Sudheer Kumar Katari,
  • Chiranjeevi Pasala,
  • Ravina Madhulitha Nalamolu,
  • Umakanth Naik Vankadoth,
  • Sharon Priya Alexander,
  • Siva Ranjani Pakala,
  • Aparna R Bitla,
  • Amineni Umamaheswari

DOI
https://doi.org/10.4103/JCSR.JCSR_67_19
Journal volume & issue
Vol. 8, no. 3
pp. 145 – 150

Abstract

Read online

Matrix metalloproteinases (MMPs) are secretary or membrane type proteolytic enzymes that act on extracellular matrix protein components such as collagens, gelatins, elastins, laminins, fibronectins, and integrins. MMPs are synthesized as zymogens and are activated to functional forms on autoproteolysis or by other proteases. Naturally, the activity of MMPs was regulated by specific tissue inhibitors of metalloproteinases and transcriptionally regulated by miRNAs. MMPs have an important role in tissue remodeling by regulating cell death, morphogenesis, and wound healing activity. Overexpression of MMPs leads to various pathologies predominantly cancer, cardiovascular, and neurological diseases. Impact of MMPs on breast cancer progressions such as proliferation, angiogenesis, invasion, and metastasis are focused in this review.

Keywords